New introductions and price growth driving pharma market growth
The pharma industry registered a 7.5% value growth year-on-year for the month of February, with sales of ₹18,781 crore, ...
Alex Warren Announces Upgrades For All Shows + New Adelaide & Second Sydney Shows Added Due To Phenomenal Demand!
Due to phenomenal presale ticket demand for Alex Warren’s Cheaper Than Therapy Global Tour, Frontier Touring is thrilled to ...
pharmaphorum1d
Novo Nordisk’s diabetes treatments approved in EU
The European Commission has granted marketing authorisation for Novo Nordisk’s adult diabetes treatments Tresiba and Ryzodeg. The approval covers all 27 European Union member states. Tresiba ...
Easter Egg-Citement Awaits In Seasonal Addition To The Hit ‘New Bum’ Series
Easter Bunny needs a NEW BUM! is the newest addition to the hilarious hit series that cracks up readers around the world.
Hosted on MSN25d
NVO Q4 Earnings Beat Estimates, GLP-1 Drugs Boost Sales, Stock Up
NovoRapid revenues increased 62% and Human insulin revenues increased 11%. Premix insulin (Ryzodeg and NovoMix) revenues grew 33% year over year. Sales of long-acting insulins (Tresiba ...